(Q43653603)

25 November 2017

title

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy (English)

1 reference

25 November 2017

1 reference

Lambright ES

1

1 reference

25 November 2017

Amin K

2

1 reference

25 November 2017

Wiewrodt R

3

1 reference

25 November 2017

Force SD

4

1 reference

25 November 2017

Lanuti M

5

1 reference

25 November 2017

Propert KJ

6

1 reference

25 November 2017

Litzky L

7

1 reference

25 November 2017

Kaiser LR

8

1 reference

25 November 2017

Albelda SM

9

1 reference

25 November 2017

language of work or name

1 reference

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

8

1 reference

25 November 2017

issue

12

1 reference

25 November 2017

page(s)

946-953

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301489

25 November 2017

exact match

0 references

cites work

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Replicating vectors for gene therapy of cancer: risks, limitations and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Replication-selective adenoviruses as oncolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Studies on the use of viruses in the treatment of carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Present status of oncolytic virus studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Replication-selective microbiological agents: fighting cancer with targeted germ warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

A method of limited replication for the efficient in vivo delivery of adenovirus to cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Immunomodulation of cancer: potential use of selectively replicating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301489

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301489

1 reference

Dimensions Publication ID

25 November 2017

1029446612

0 references

1 reference